Literature DB >> 16162800

Cerebrospinal fluid leak and meningitis associated with nasal continuous positive airway pressure therapy.

Tomasz J Kuzniar1, Benjamin Gruber, Gökhan M Mutlu.   

Abstract

Clear rhinorrhea is a common symptom in patients with obstructive sleep apnea (OSA) and may worsen with continuous positive airway pressure therapy. Clear rhinorrhea can also be the presenting symptom of cerebrospinal fluid (CSF) leak, which is evidence of a communication between the subarachnoid space and the nasal cavity or sinuses. While CSF leak has been reported to occur with nasal continuous positive airway pressure (nCPAP) therapy following trauma to the skull base, its association with OSA and nCPAP therapy in the absence of trauma has not been previously described. We report two patients with OSA in whom CSF leak developed following the institution of nCPAP therapy. In one patient, the rhinorrhea was complicated by meningitis. Both patients underwent successful repair of their defects. One patient successfully restarted nCPAP therapy, while the other refused it.

Entities:  

Mesh:

Year:  2005        PMID: 16162800     DOI: 10.1378/chest.128.3.1882

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

1.  Cerebrospinal fluid leak associated with nasal continuous positive airway pressure treatment for obstructive sleep apnoea.

Authors:  Jean Yared; Jaafar El Annan
Journal:  BMJ Case Rep       Date:  2010-09-07

2.  Resumption of Positive-Pressure Ventilation Devices for Obstructive Sleep Apnea following Transsphenoidal Surgery: An Institutional Experience of a Surgical Cohort.

Authors:  Nicholas Gravbrot; Heidi Jahnke; William L White; Andrew S Little
Journal:  J Neurol Surg B Skull Base       Date:  2019-05-17

3.  Should we take precautions to avoid respiratory compromise while delaying CPAP resumption following transsfenoidal surgery? An alternative approach in a patient with severe obstructive sleep apnea: case report.

Authors:  Yılmaz Yenigün; Anıl Özonur; Kamil Mehmet Tuğrul; Uğur Özbek; Nurperi Gazioğlu
Journal:  Acta Neurochir (Wien)       Date:  2022-04-28       Impact factor: 2.216

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.